title: When Off-label is Illegal: Implications of Mandating the FDA-approved Protocol for Mifepristone-induced Abortions.
authors.affiliation: School of Nursing, University of North Carolina, Chapel Hill, North Carolina. Electronic address: laurabritton@gmail.com.
authors.forename: Laura
authors.initials: L
authors.lastname: Britton
authors.affiliation: Division of Family Planning, Department of Obstetrics & Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
authors.forename: Amy
authors.initials: A
authors.lastname: Bryant
mesh_terms: D000021:Abortifacient Agents, Steroidal / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000379:methods*; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use*; D009774:Obstetrics; D056687:Off-Label Use; D010818:Practice Patterns, Physicians'; D011247:Pregnancy; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone